The activities of Bureau LEGINT
to assist in the transfer of new technologies
in the pharmaceutical industry
Bureau LEGINT, as part of the implementation of tasks to strengthen the position of Russian pharmaceutical enterprises in Africa and the Middle East, is actively working to promote them in the markets of the region, organizing contacts with potential customers of products. With the assistance of Bureau LEGINT, a batch of the «Sputnik» vaccine was delivered to Burkina Faso in June 2021.
Bureau’s employees monitor the needs of friendly states for Russian pharmaceutical products, as well as existing technologies for the production of medications that are not produced in the Russian Federation, but for which there is a need in the domestic market.
In September of this year, Bureau LEGINT, with the participation of General Director A. Samarkina, organized a joint working meeting of the General Director of the ChemRar Research Institute A. Sizyukhin with the General Director of Farmintensive Life LLC E. Atrash and company employees on the possible transfer of technologies for the production of medications for both domestic, and for foreign markets. The parties exchanged views on the prospects for cooperation and got acquainted with the possibilities of high-tech production at the site of the ChemRar Research Institute.
Bureau Legint (https://legint.com/), an association of professionals from various fields of government, commercial and information and analytical activities, offers comprehensive solutions in the field of international promotion of national initiatives and business interests, primarily in Africa and the Middle East. The Bureau is one of the proactive founders of the Association of Economic Cooperation with African States (AEСAS), created on behalf of the President of the Russian Federation (https://africa-rus.com/).
Research Institute “ChemRar” is one of the leaders in the contract development of innovative chemical biotechnological drugs in Russia. Experience in the international market, regular audits of the quality of research from Russian and foreign customers, and the availability of modern infrastructure allow the ChemRar Research Institute to carry out research at the highest level (https://chemrar.ru/).